You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Mallinckrodt
Merck
Express Scripts
Boehringer Ingelheim

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PTI-428

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for PTI-428?

PTI-428 is an investigational drug.

There have been 22 clinical trials for PTI-428. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Fibrosis, Cystic Fibrosis, and Alzheimer Disease. The leading clinical trial sponsors are Proteostasis Therapeutics, Inc., Pain Therapeutics, and Cassava Sciences, Inc.

Recent Clinical Trials for PTI-428
TitleSponsorPhase
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular EdemaHoffmann-La RochePhase 3
PTI-125, 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsNational Institute on Aging (NIA)Phase 2
PTI-125, 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsCassava Sciences, Inc.Phase 2

See all PTI-428 clinical trials

Clinical Trial Summary for PTI-428

Top disease conditions for PTI-428
Top clinical trial sponsors for PTI-428

See all PTI-428 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Mallinckrodt
Merck
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.